WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 12'4601 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 20'3231 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 44'271  43'847  43'418  42'982  42'540  37'057  32'730  28'106 
Births 751  753  754  754  754  720  714  692 
Surviving infants 742  743  744  744  744  707  696  667 
Pop. less than 5 years 3'737  3'736  3'718  3'705  3'681  3'472  3'415  3'317 
Pop. less than 15 years 11'017  10'988  10'940  10'895  10'834  10'370  10'020  8'524 
Female 15-49 years 11'018  10'909  10'804  10'701  10'601  9'192  7'820  6'753 

Number of reported cases

(Click for retrospective incidence data for Argentina)
Diphtheria
ChartChart
  31  86 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  1'967  16'102 
Mumps
ChartChart
  4'396  74  156  87  3'772 
Pertussis
ChartChart
  864  1'686  975  561  1'112  515  2'012  27'223 
Polio*
ChartChart
  32 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  11  12  49  219 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Argentina)
Vaccine year result method % card seen                                                
BCG          95  92  99*  99*  99*  71  99*  62 
DTP1          91  88  94  98  94  88 
DTP3          86  92  94  94  94  83  87  44 
DTP4          73  79  74  84 
IPV1          91  56 
HepB_BD          80  81  84  87  85 
HepB3          86  92  94  94  94 
Hib3          86  92  94  94  94  83 
JapEnc         
MCV1          89  90  89  95  94  91  93  61 
MCV2          89  88  87  96  99*  56 
MenA         
PCV1          88  88  92  99  98 
PCV2          83  84  87  93  90 
PCV3          76  82  82  89  86 
Pol3          84  87  93  92  90  88  90  33 
Rota1          87  85  83 
RotaC          78  75  61 
RCV1          89  90  89  95  94 
TT2plus 2011  43  MICS     72  82  62  95 
PAB         
VAD1         
YFV          74  72  60  51  91 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Argentina)
BCG
ChartChart
  96  96  99  99  95  99  62 
DTP1
ChartChart
  94  94  98  94  96  95  69 
DTP3
ChartChart
  94  94  94  94  83  87  44 
HepB3
ChartChart
  94  94  94  94 
HepB_BD
ChartChart
  84  84  87  85 
Hib3
ChartChart
  94  94  94  94  83 
IPV1
 
MCV1
ChartChart
  89  89  95  94  91  93  61 
MCV2
ChartChart
  87  87  96  83  56 
PCV3
ChartChart
  82  82  89  86 
Pol3
ChartChart
  93  93  92  90  88  90  33 
RCV1
ChartChart
  89  89  95  94  91 
RotaC
ChartChart
  61  61 
YFV
ChartChart
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 512  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
142 
   
/
|
|
\
Greater or equal to 90% 46
From 80 to 89% 27
From 50 to 79% 23
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; Yes
CHOLERA Yes militaries
DTaPHibHepBIPV 2, 4, 6 months; Yes preterm newborns weighing less than 1500 grams at birth and <6 months
DTwP 6 years; Yes
DTwPHibHepB 2, 4, 6, 15-18 months; Yes
HepA_Adult Yes special indications: MSM, patients with coagulation disorders, chronic liver disease, work with the HAV in laboratories, culinary staff, nursery staff who assist children under one year of age, travelers to high or medium endemic areas
HepA_Pediatric 12 months; Yes
HepB_Adult 0, 1, 6 months; Yes
HepB_Pediatric birth; Yes
HIB Yes premature babies
HPV 11 years (x2); Yes women born after 2000, men born in 2006 who have completed 11 years
Influenza_Adult =>65 years; Yes and adults with chronic illness, pregnant women, health care workers, other risk groups
Influenza_Pediatric 6-24 months; Yes and children with chronic illness
IPV 2, 4 months; Yes
MenACWY-135 conj 3, 5, 15 months; 11 years; Yes
MMR 1, 6 years; Yes and Y11 if not yet vaccinated
OPV 6, 15-18 months; 6 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >65 years; Yes and risk groups
Rabies Yes pre-exposure prophylaxis for people working with the virus in the laboratory; prophylaxis-post-exposure treatment against rabies
Rotavirus 2, 4 months; Yes
Td Yes adults every 10 years
Tdap 11 years; Yes HCWs and pregnant women from week 20 of pregnancy
Varicella 15 months; Yes
YF 18 months; 11 years; No populations in risk zones, travellers to risk zones
Zoster Yes for prophylaxis against people exposed to varicella virus for prophylaxis against people exposed to varicella virus for prophylaxis against people exposed to varicella virus

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2017-2018  2011-2016  2011-2016  2011-2016  2011-2016  2010-2015  2012-2016 
Nº of districts with microplans that include activities to raise immunization coverage number   12    24  24  129 

System performance

Total Nº districts in country number 512  512  511  511  511  511   
Nº districts with DTP3 coverage >=80% number 371  400  459  440  452  430  381 
% of districts with DTP3 coverage >=80% From 0 to 100% 72  78  90  86  88  84   
Nº districts with measles (MCV1) coverage >=95% number 178  234  264  286  295  270  254 
% of districts with MCV1 coverage >=95% From 0 to 100% 35  46  52  56  58  53   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  60  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.